Pfizer: revenue, profit and dividends

In fiscal 2025, Pfizer had revenue of $62.6B, up 2.5% a year on average since 2015, and net income of $7.77B (12.4% of revenue). Its dividend per share has gone up 15 years in a row, to $1.72. It has 9% fewer shares than in 2015.

Revenue, fiscal 2025

$62.6B+2.5% a year

average annual revenue growth since 2015 · −1.6% vs 2024

Net income, 2025

$7.77B

12.4% of revenue

Diluted EPS, 2025

$1.36

2.1% a year since 2015

Dividend per share, 2025

$1.72

raised 15 years in a row

Revenue growth, 5 years

8.5% a year

since 2020

Shares, 2025

5.71B

−8.7% since 2015

Free cash flow, 2025

$9.07B

$11.7B from operations − $2.63B capex

Ticker: PFE · NYSE
Sector: Health Care
Sub-industry: Pharmaceuticals
Headquarters: New York City, New York
Founded: 1849
In the S&P 500 since: March 4, 1957, the index’s first day
Latest fiscal year: 2025, ended December 31, 2025
SEC filer: Pfizer Inc · CIK 0000078003

Revenue and net income

Revenue went from $48.4B in 2007 to $62.6B in 2025.

RevenueNet income

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Diluted earnings per share

Diluted EPS went from $1.17 in 2007 to $1.36 in 2025. Ten-year growth: 2.1% a year.

Fiscal years · US dollars per share, adjusted for splitsSource: SEC EDGAR (company filings)

Dividends per share

Raised 15 years in a row, every year from 2011 to 2025. Ten-year growth: 4.4% a year.

Fiscal years · US dollars per share, adjusted for splitsSource: SEC EDGAR (company filings)

Shares outstanding

8.7% fewer shares in 2025 than in 2015 (6.26B → 5.71B): buybacks outweighed new shares.

Fiscal years · diluted weighted-average shares, adjusted for splitsSource: SEC EDGAR (company filings)

Operating cash flow, capex and free cash flow

Free cash flow (operating cash flow minus capital expenditure) was $9.07B in 2025, 14.5% of revenue.

Operating cash flowCapital expenditureFree cash flow

Fiscal years · US dollarsSource: SEC EDGAR (company filings)

Year by year

Fiscal year	Revenue	Net income	Net margin	Diluted EPS	Dividend	Shares	Operating cash flow	Capex	Free cash flow
2025	$62.6B	$7.77B	12.4%	$1.36	$1.72	5.71B	$11.7B	$2.63B	$9.07B
2024	$63.6B	$8.03B	12.6%	$1.41	$1.69	5.7B	$12.7B	$2.91B	$9.84B
2023	$59.6B	$2.12B	3.6%	$0.37	$1.65	5.71B	$8.7B	$3.91B	$4.79B
2022	$101B	$31.4B	31.0%	$5.47	$1.61	5.73B	$29.3B	$3.24B	$26B
2021	$81.3B	$22B	27.0%	$3.85	$1.57	5.71B	$32.6B	$2.71B	$29.9B
2020	$41.7B	$9.16B	22.0%	$1.63	$1.53	5.63B	$14.4B	$2.23B	$12.2B
2019	$40.9B	$16B	39.2%	$2.82	$1.46	5.67B	$12.6B	$2.05B	$10.5B
2018	$40.8B	$11.2B	27.3%	$1.87	$1.38	5.98B	$15.8B	$1.98B	$13.8B
2017	$52.5B	$21.3B	40.6%	$3.52	$1.30	6.06B	$16.8B	$1.96B	$14.8B
2016	$52.8B	$7.21B	13.7%	$1.17	$1.22	6.16B	$16.2B	$1.82B	$14.4B
2015	$48.9B	$6.96B	14.2%	$1.11	$1.12	6.26B	$14.7B	$1.4B	$13.3B
2014	$49.6B	$9.13B	18.4%	$1.42	$1.04	6.42B	$17.1B	$1.2B	$15.9B
2013	$51.6B	$22B	42.7%	$3.19	$0.96	6.89B	$17.7B	$1.21B	$16.5B
2012	$54.7B	$14.6B	26.7%	$1.94	$0.88	7.51B	$16.7B	$1.33B	$15.4B
2011	$61B	$10B	16.4%	$1.27	$0.80	7.87B	$20.2B	$1.66B	$18.6B
2010	$65.2B	$8.26B	12.7%	$1.02	$0.72	8.07B	$11.5B	$1.51B	$9.94B
2009	$49.3B	$8.63B	17.5%	$1.23	—	7.04B	$16.6B	$1.21B	$15.4B
2008	$48.3B	$8.1B	16.8%	$1.20	—	6.75B	$18.2B	$1.7B	$16.5B
2007	$48.4B	$8.14B	16.8%	$1.17	—	6.94B	$13.4B	$1.88B	$11.5B